Quest Laboratories
QUESTLAB · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
9.9%
1m
26.7%
3m
36.7%
6m
55.3%
all
37.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 137 0%
101
153
Company Overview

Sales
94.3 Cr
Growth: 43.9%
Profit after Tax
12.9 Cr
Growth: -13.6%
Micro Cap
224 Cr
P/E: 17.3x
Industry P/E: 30.4x
Fundamentals

Sales (Cr) ₹ 94.3
Growth 43.9%
EBITDA 15.7%
P/S 2.4x
Dividend 0.0%
P/E 17.3x
Book Value ₹ 10
PEG Ratio 0.4x
ROE 78.9%
P/B N/A
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is primarily engaged in the manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company also produces variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
Belongs to (1 Indices)